During the past decade, Alta Pharmaceutical Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alta Pharmaceutical Research Center" #1 sponsor was "Mannkind Corporation" with 7 trials, followed by "Arrowhead Pharmaceuticals" with 2 trials sponsored, "NewAmsterdam Pharma" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alta Pharmaceutical Research Center" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alta Pharmaceutical Research Center" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Dyslipidemias" (2 trials), "Type 2 Diabetes" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Alta Pharmaceutical Research Center" in a lesser frequency.

Most popular intervention types in "Alta Pharmaceutical Research Center" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Technosphere® Insulin Inhalation Powder" (3 trials), "ARO-APOC3" (2 trials), "Obicetrapib" (2 trials) and "Technosphere Insulin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alta Pharmaceutical Research Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Alta Pharmaceutical Research Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Alta Pharmaceutical Research Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Alta Pharmaceutical Research Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".